glp-1 receptor agonist type 1 diabetes randomized trial Clinical efficacy results from clinical trials comparing different GLP-1 receptor agonists in the
Description
(Ahmed Abdelmaksoud) and M.S.F
Combination therapy with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors in older patients with type 2 diabetes: a real-world evidence study
The use of more than one antidiabetic medication was reported in 73 (46.8%) cases
Nausea is the most common symptom, reported by about 25% of users, with vomiting and diarrhoea reported by about 10%
You should hear a click, followed by a second click, 10 to 15 seconds later once the injection has finished
The starting dose for most treatment arms was 0.5mg weekly for the first two weeks
